Community/Retail

If approved, brensocatib will be the first and only approved treatment for bronchiectasis and the first within a new class of medicines, called dipeptidyl peptidase 1 inhibitors.

Pharmacists can recommend vitamin D supplements and vitamin D-rich foods to support healthy pregnancy outcomes.

The decision to end HYPERION (NCT04811092) comes after positive results from an interim analysis of the ZENITH trial (NCT04896008).

Vietnam war trauma continues to affect veterans’ health 50 years later.

The authors are optimistic that this method can be replicated to identify other allergens that manifest into eosinophilic esophagitis (EoE).

The speed and scale of what’s coming with AI can only be imagined now, but without a doubt, our lives will change.

In the phase 3 CONNEX clinical trial program, iclepertin did not meet its primary and secondary end points.

Proper nutrition and awareness of potential side effects from GLP-1 medications are essential for patients undergoing treatment.

Age, body mass index, and male sex are also associated with the development of diabetes.

The decision offers patients with antimicrobial resistance, who have limited or no treatment options, a new alternative.

New therapies are being developed for individuals with gout.

Donna Ryan discusses the landscape of GLP-1 medications and the lineup of indications that the drug class has received indications for in recent years.

The demands of the pharmacy profession—long hours, high stress, and emotional strain—can take a toll on pharmacists’ well-being.

There were no substantial differences for the mindfulness with substance use or anxiety outcomes compared with the recovery control group.

Pregnant individuals with multiple sclerosis (MS) are more likely to experience mental illness both during their pregnancy and in the first years after giving birth.

Ulipristal is a progesterone receptor modulator that prevents pregnancy by blocking the release of an egg from the ovary and inhibiting implantation in the uterus.

The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board for a different approach.

Efruxifermin is undergoing 3 phase 3 clinical trials to evaluate its safety, efficacy, and tolerability in metabolic dysfunction-associated steatohepatitis (MASH).

Investigators noted that the differences between the 3 respiratory infections were not as pronounced during the 2023-2024 season.

Investigators found that 60% of individuals with type 2 diabetes are vitamin D deficient.

Prescription stimulant dispensing was greatly impacted by the COVID-19 pandemic and drug shortages.

The results highlight hemoglobin A1c/high-density lipoprotein cholesterol as a potential clinical marker for long-term stroke risk.

For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.

Overall, there is no long-term increased risk of developing thyroid cancer after initiating treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, although there is a short-term increase.

Angiotensin receptor neprilysin inhibitors show promise as an alternative to standard management of resistant hypertension.

The approval marks the first subcutaneous infusion device approved for the treatment of Parkinson disease, providing a new option for patients with serious disease who are unresponsive to other therapies.

World Cancer Day, observed annually on February 4th, is a global initiative aimed at raising awareness, reducing stigma, and promoting equitable access to cancer care, with pharmacy professionals playing a vital role in prevention, treatment, and support for patients and communities.